APA (7th ed.) Citation

Koram, K. A., Adu, B., Ocran, J., Karikari, Y. S., Adu-Amankwah, S., Ntiri, M., . . . Nkrumah, F. (2016). Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study. PLoS ONE, 11(9), 1. https://doi.org/10.1371/journal.pone.0163066

Chicago Style (17th ed.) Citation

Koram, Kwadwo A., et al. "Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study." PLoS ONE 11, no. 9 (2016): 1. https://doi.org/10.1371/journal.pone.0163066.

MLA (9th ed.) Citation

Koram, Kwadwo A., et al. "Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study." PLoS ONE, vol. 11, no. 9, 2016, p. 1, https://doi.org/10.1371/journal.pone.0163066.